Tucked into its latest earnings report, Eli Lilly disclosed that it has removed from its research pipeline an experimental drug for pain. The drug, which Lilly in-licensed several years ago, works by ...

Pharmaceutical giants AstraZeneca, Eli Lilly & Co. and Merck & Co. have committed a cumulative $120 million to develop a workforce training center for advanced pharmaceutical manufacturing in Central ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. A sign for Eli Lilly & Co. stands outside their ...

Despite the largest U.S. pharmacy benefit manager (PBM) knocking Zepbound off its formulary this summer, sales of Lilly’s dual-action obesity med continue to impress, thanks in no small part to the ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker. Lilly said Thursday that its ...

Indianapolis-based drug maker Eli Lilly and Co. on Wednesday announced it plans to spend more than $1.2 billion to expand and update its manufacturing site in Puerto Rico to increase production of ...

Shares of Eli Lilly And Co (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) are moving lower in Thursday’s after-hours session after President Donald Trump indicated that weight-loss drugs are going to come ...

Indianapolis. IN, October 16, 2025: U.S. pharmaceutical giant Eli Lilly and Company has announced plans to invest over $1 billion in Telangana, strengthening Hyderabad’s position as one of the world’s ...

Oct 8 (Reuters) - Telehealth company HealthTap said on Wednesday it is joining Eli Lilly's (LLY.N), opens new tab digital healthcare platform, LillyDirect, to offer virtual diabetes management ...

Approximately 80% of Omvoh-treated patients in the LUCENT-3 study who achieved clinical remission at one year maintained long-term, corticosteroid-free clinical and endoscopic remission At four years, ...